Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
31,433,108
-
Share change
-
-5,933
-
Total reported value
-
$148,928,847
-
Put/Call ratio
-
9.7%
-
Price per share
-
$4.74
-
Number of holders
-
72
-
Value change
-
-$29,537
-
Number of sells
-
2
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q4 2013
As of 31 Dec 2013,
SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,433,108 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Advisors LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, COWEN GROUP, INC., and MILLENNIUM MANAGEMENT LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.